Media Coverage

Pushing Late-Stage Treatments Forward in the Clinic

Sep 17, 2020

Treating social anxiety disorder: VistaGen and EverInsight collaborate in Asian markets

Jul 14, 2020

VistaGen out-licenses rights to anxiety disorder candidate in Asia territories

Jun 26, 2020

DocTalk Podcast: The Psychological Damage of the COVID-19 Pandemic

May 27, 2020

An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics

Mar 12, 2020

VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial

Feb 21, 2020

FDA Clears Way for Phase 2 Trial of AV-101 for Levodopa-Induced Dyskinesia

Feb 4, 2020

Investigational Dyskinesia Treatment Gets FDA Green Light

Feb 3, 2020

VistaGen to study dyskinesia drug in Phase II Parkinson’s trial

Jan 31, 2020

FDA Clears Study to Test New Drug to Treat Dyskinesia for Parkinson Patients

Jan 30, 2020

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• Next »